Monopar Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	127.68	45.82	7.27	8.19	20.3	16.74
Short-Term Investments	16	14.4	-	4.93	-	-
Cash & Short-Term Investments	143.68	60.21	7.27	13.12	20.3	16.74
Cash Growth	2286.61%	728.67%	-44.62%	-35.38%	21.31%	26.66%
Other Current Assets	0.41	0.08	0.07	0.05	0.22	0.06
Total Current Assets	144.09	60.29	7.33	13.17	20.52	16.8
Net Property, Plant & Equipment	0.11	-	0.01	0.06	-	-
Other Long-Term Assets	-	-	-	-	-	0.07
Total Assets	144.2	60.29	7.35	13.23	20.52	16.87
Accounts Payable	2.57	2.25	1.76	3.13	1.58	1.18
Accrued Expenses	-	3	-	-	-	-
Total Current Liabilities	2.57	5.25	1.76	3.13	1.58	1.18
Long-Term Leases	0.07	-	-	0.01	-	-
Total Long-Term Liabilities	0.07	-	-	0.01	-	-
Total Liabilities	2.64	5.25	1.76	3.14	1.58	1.18
Common Stock	0.01	0.01	0	0.01	0.01	0.01
Additional Paid-in Capital	225.85	130.79	65.81	61.87	60.22	47.87
Accumulated Other Comprehensive Income	0.01	0.04	-0.01	0.01	-0	-0.01
Retained Earnings	-84.31	-75.79	-60.21	-51.8	-41.29	-32.19
Shareholders' Equity	141.56	55.04	5.59	10.09	18.94	15.69
Total Liabilities & Equity	144.2	60.29	7.35	13.23	20.52	16.87
Total Debt	0.07	0	0	0.01	0	0
Net Cash (Debt)	143.6	60.21	7.27	13.11	20.3	16.74
Net Cash Growth	138.50%	728.67%	-44.58%	-35.42%	21.31%	26.66%
Net Cash Per Share	22.08	15.89	2.63	5.16	8.14	7.64
Book Value	141.56	55.04	5.59	10.09	18.94	15.69
Book Value Per Share	21.77	14.52	2.02	3.97	7.59	7.16
Tangible Book Value	141.56	55.04	5.59	10.09	18.94	15.69
Tangible Book Value Per Share	21.77	14.52	2.02	3.97	7.59	7.16

Updated Nov 13, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q